Clinical Trial

Kinetics of Urinary Excretion of Gadolinium Contrast Agents Used in MRI Examinations

Study acronym: GADODURABLE
Recruiting
View on ClinicalTrials.gov →
Summary
This is a single-center cohort study aimed to describe the urinary excretion kinetics of gadolinium contrast agents (Gd-CAs). Patients with a prescription for injected MRI are invited to participate in the study. If they agree, blood and urine samples are collected before Gd-CAs injection, and urine samples are collected between 0- and two-and-a-half-hours post-injection of Gd-CAs.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-12-20; most recent amendment 2026-06-20.
Status change: Not Yet Recruiting → Recruiting 2024-04-15
Trial Details
NCT Number NCT06191731
Lead Sponsor Centre Hospitalier Régional Metz-Thionville
Collaborators: University of Lorraine
Conditions Magnetic Resonance Imaging
Enrollment 60 participants
Start Date 2024-04-12
Primary Completion 2028-04-12 (estimated)
Study Completion 2028-04-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-24